Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Contineum Therapeutics (CTNM) Tax Provisions (2023)

Contineum Therapeutics' Tax Provisions history spans 1 years, with the latest figure at -$161000.0 for Q4 2023.

  • Quarterly Tax Provisions changed N/A to -$161000.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was -$161000.0 through Sep 2024, changed N/A year-over-year, with the annual reading at $450000.0 for FY2023, N/A changed from the prior year.
  • Tax Provisions came in at -$161000.0 for Q4 2023, down from -$100000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $700000.0 in Q2 2023 to a low of -$161000.0 in Q4 2023.